Table 1.

Baseline patient and disease characteristics from 822 patients on E2805 for which adequate primary RCC tissue was available for analysis

N (%)
SexFemale289 (35.2)
Male533 (64.8)
Age≤48226 (27.5)
49–56220 (26.8)
57–64186 (22.6)
≥65190 (23.1)
HistologyClear cell676 (82.2)
Chromophobe31 (3.8)
Papillary64 (7.8)
Other51 (6.2)
Sarcomatoid featuresNo748 (91.0)
Yes73 (8.9)
Missing1 (0.1)
Fuhrman grade1/2310 (37.7)
3/4512 (62.3)
Path T-stage184 (10.2)
2236 (28.7)
3491 (59.7)
411 (1.3)
Path N-stage0299 (36.4)
137 (4.5)
223 (2.8)
X463 (56.3)
ArmSunitinib273 (33.2)
Sorafenib272 (33.1)
Placebo277 (33.7)